“I expect the role of LAI Invega Trinza on schizophrenia”

In the market of schizophrenia, whose key of treatment is to prevent recurrence prevention, the domestic approval of ‘Invega Trinza,’ a long-acting injection(hereinafter referring to LAI), has attracted attention.

At the Janssen Korea’s MFDS(Ministry of Food and Drug Safety) Approval Commemorative Meeting for ‘Invega Trinza(generic name: paliperidone palmitate’ on the 5^th, Professor Sang-hyuk ...